HealthQuill Non-invasive Treatment
A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other hard-to-reach tumours will be installed at the UK’s Cambridge University Hospitals later this year.
Drugs Health Pharma

UK patients to be first to get non-invasive liver cancer treatment in Europe

HQ Team June 12, 2025: A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other.

Read More